Balyasny Asset Management’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-132,110
Closed -$5.11M 3179
2023
Q1
$5.11M Buy
+132,110
New +$4.26M 0.01% 1069
2022
Q4
Sell
-22,657
Closed -$474K 3388
2022
Q3
$556K Sell
22,657
-75,143
-77% -$1.99M ﹤0.01% 2005
2022
Q2
$1.61M Hold
97,800
0.01% 1525
2022
Q1
$2.63M Buy
97,800
+56,800
+139% +$1.2M 0.01% 1249
2021
Q4
$1.36M Buy
+41,000
New +$1.55M ﹤0.01% 1370
2021
Q3
Sell
-194,019
Closed -$11.4M 2566
2021
Q2
$11.4M Buy
+194,019
New +$11.5M 0.05% 467

Other funds holding OSH

Balyasny Asset Management's OSH Position: Q2 2023 in Review

Balyasny Asset Management sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 132,110 shares — an estimated $5.11M sold.

Balyasny Asset Management first reported a position in OSH in Q2 2021 and held it in 6 quarters. The position peaked at $11.4M in Q2 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Balyasny Asset Management reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 132,110 Oak Street Health, Inc. shares in Q2 2023, an estimated $5.11M.
  • Balyasny Asset Management first reported a position in Oak Street Health, Inc. in Q2 2021 and held it in 6 quarters.
  • Balyasny Asset Management's Oak Street Health, Inc. position peaked at $11.4M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.